Nattokinase: Blood Pressure Evidence, Graded
Share
The honest verdict
A modest blood-pressure supplement with a real bleeding risk — not the clot-dissolving Long-COVID fix it is marketed as.
Nattokinase carries some of the boldest claims in the supplement aisle, and some of the most serious safety caveats. Both deserve to be stated plainly.
What the evidence actually supports
Lowers blood pressure (meta-analysis of 6 RCTs)
Real but small: −3.45 mmHg systolic, −2.32 mmHg diastolic across 6 RCTs (n=546).
Lowers blood pressure (single independent RCT)
2,000 FU/day for 8 weeks cut systolic 5.55 mmHg, diastolic 2.84 mmHg vs control.
Cholesterol and lipid profile
Inconsistent, dose-dependent across pooled trials; glucose rose slightly in some.
"Dissolves" blood clots and microclots in the body
Only shown in a test tube; no human trial has shown it clears clots in the body.
Long-COVID "de-clotting" / symptom relief
No published human RCT; the claim rests on lab assays and marketing content.
General cardiovascular / thrombosis prevention
No trials on stroke, heart attack or DVT rates. A mechanism is not an outcome.
Safe to combine freely with blood thinners
False. Bleeding risk is additive with warfarin, DOACs and aspirin.
Grades assigned by Pure City Research from human trials only · ultimately funded by consumers through Pure City Shop · study funding traced.
Every grade above is assigned by Pure City Research from human trials only. Pure City Shop funds the research, and people fund the Shop through purchases and product pre-orders—so the research is ultimately funded by consumers. Study funding is traced, and where the evidence is weak, we say so.
The numbers worth knowing
2,000 FU/day
The dose used in the trials (~100 mg standardized extract)
−3.45 mmHg
Pooled systolic BP drop across 6 RCTs
0
Human RCTs testing the microclot or Long-COVID claim
546
Total participants pooled across the 6 blood-pressure RCTs
8 weeks
Length of the pivotal RCT in 86 pre-/stage-1 hypertensive adults
The dose
The dose
2,000 FU/day (~100 mg), enteric-coated capsule
Every human trial behind the blood-pressure claim used roughly 2,000 FU/day of a standardized, enteric-coated extract — the coating is meant to get the enzyme past stomach acid — for 8 weeks in the pivotal RCT, with durations varying across the 6 pooled RCTs. Nothing in the evidence supports going higher: lipid effects were inconsistent and dose-dependent, bleeding is the dose-limiting risk, and there is no established dose at all for "dissolving microclots" or Long-COVID because no human dosing trial has ever tested that outcome.
Ceiling: Evidence stops at about 2,000 FU/day over 8 weeks. No studied dose above that, and no dosing trial of any size for microclot or Long-COVID use.
Hype vs evidence
The hype
Nattokinase dissolves clots and microclots in the bloodstream.
The evidence
The viral claim that nattokinase dissolves clots or microclots and reverses Long-COVID has never been tested in a single human trial — it rests entirely on test-tube assays where the enzyme is dripped onto fibrin outside the body.
Safety and interactions
Common side effects
- Generally well tolerated; supplement use up to ~3 years appears safe in available reports
- Occasional, mild gastrointestinal upset (anecdotal, not a theme in the pivotal trials)
- Bleeding or bruising — rare but serious, and the primary safety concern
- Allergic reaction — uncommon; it is a soy-fermentation product
- Variable vitamin K2 content depending on the specific product
Interactions that matter
- Anticoagulants (warfarin, apixaban, rivaroxaban, dabigatran) — additive interference with clotting; avoid without direct medical supervision
- Antiplatelets (aspirin, clopidogrel) — additive antiplatelet/fibrinolytic effect, increased bleeding risk
- Other fibrinolytic or thrombolytic drugs — directly additive mechanism; avoid the combination
- Surgery and dental procedures — discontinue beforehand; elevated bleeding risk during and after
- Antihypertensive medications — additive blood-pressure lowering; monitor for hypotension
- Vitamin K2 endogenous to natto-derived products — can antagonize warfarin and reduce its effectiveness, the opposite direction from the enzyme's own effect
- Other supplements with antiplatelet activity (high-dose fish oil, ginkgo, vitamin E) — potential additive bleeding risk; no dedicated human interaction trials exist
Talk to a clinician first if any of these apply:
- You take anticoagulants (warfarin, apixaban, rivaroxaban, dabigatran) or antiplatelets (aspirin, clopidogrel) without explicit medical guidance
- You have surgery or a dental procedure scheduled in the near future
- You have a bleeding disorder such as hemophilia or von Willebrand disease, or a history of hemorrhagic stroke
- You have active peptic ulcers or another condition with elevated bleeding risk
- You are pregnant or breastfeeding — safety has not been established
- You have a soy allergy
- You take warfarin and are not tracking the vitamin K2 content of your specific product
Questions people actually ask
Will this dissolve clots or microclots in my body?
No human trial has ever tested that. The claim comes from lab assays where the enzyme is added directly to blood plasma or fibrin plates outside the body. That cannot show a swallowed capsule survives digestion, is absorbed intact, reaches a clot, and does the same thing inside a living person. Graded Insufficient.
Does nattokinase help with Long-COVID?
There is no published randomized controlled trial testing nattokinase for Long-COVID symptoms or microclot burden. The narrative traces back to in-vitro research and to content published by sellers of specific purified nattokinase extracts. Graded Insufficient. There is also no established dose for this use, because no human dosing trial has tested it.
So what does it actually do?
It lowers blood pressure modestly. A meta-analysis of 6 RCTs in 546 people found systolic down 3.45 mmHg and diastolic down 2.32 mmHg. An independent 8-week RCT in 86 pre- and stage-1 hypertensive adults found 5.55 and 2.84 mmHg at 2,000 FU/day. Real and statistically significant, but roughly the range of cutting salt.
Can I take it with aspirin or warfarin?
Not without medical supervision. Nattokinase's fibrinolytic action is additive with warfarin, DOACs like apixaban and rivaroxaban, and antiplatelets like aspirin and clopidogrel, and case reports of bleeding events exist. Stop before any scheduled surgery or dental work. On warfarin, also check the product's vitamin K2 content, which pulls the opposite way.
Is nattokinase FDA-approved?
No. It is sold in the United States as a dietary supplement, not an approved drug, and carries no FDA-approved claim to treat, prevent, or dissolve blood clots. Natto itself is a traditional Japanese food with centuries of dietary use, but the concentrated enzyme has never gone through drug approval for any thrombosis-related indication.
What about cholesterol and triglycerides?
Pooled trial data show inconsistent, dose-dependent effects on lipids, alongside a small rise in blood glucose in some trials. We grade this Weak — not a clear or reliable benefit. If improving your lipid panel is the reason you are considering nattokinase, the current human evidence does not support that purchase.
This guide is a condensed, visual adaptation. The full analysis — every citation, funding trace and evidence ceiling — lives at Pure City Research.
Read the full Nattokinase 2000 FU analysis at Pure City Research →
Pre-order Nattokinase 2000 FUFirst production run · how pre-ordering works · automatic refund if not shipped by 30 November 2026.